CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 2,4-di-tert-butylphenol
Accession: CHEBI:89188
browse the term
Definition: A member of the class of phenols carrying two tert-butyl substituents at positions 2 and 4.
Synonyms: related_synonym: 1-Hydroxy-2,4-di-tert-butylbenzene; 2,4-Bis(1,1-dimethylethyl)phenol; 2,4-Bis(tert-butyl)phenol; 2,4-Di-t-Butylphenol; 2,4-Tert-butylphenol; Formula=C14H22O; InChI=1S/C14H22O/c1-13(2,3)10-7-8-12(15)11(9-10)14(4,5)6/h7-9,15H,1-6H3; InChIKey=ICKWICRCANNIBI-UHFFFAOYSA-N; SMILES=OC1=CC=C(C(C)(C)C)C=C1C(C)(C)C
xref: CAS:96-76-4; HMDB:HMDB0013816
xref_mesh: MESH:C056559
xref: PMID:16595909; PMID:22020168; PMID:23450232; PMID:24074359; PMID:24934765; PMID:25641715; PMID:27107984; PMID:27524650; Reaxys:1910383
G
Esrrg
estrogen-related receptor gamma
increases activity
ISO
2,4-di-tert-butylphenol results in increased activity of ESRRG protein
CTD
PMID:31127318
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
2,4-di-tert-butylphenol inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
ISO
[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with Fibroblast Growth Factor 2] results in increased expression of KEAP1 mRNA
CTD
PMID:36682590
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Meox1
mesenchyme homeobox 1
multiple interactions
ISO
[Chir 99021 co-treated with 2,4-di-tert-butylphenol] results in decreased expression of MEOX1 mRNA
CTD
PMID:36682590
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
G
Nanog
Nanog homeobox
multiple interactions
ISO
[Chir 99021 co-treated with 2,4-di-tert-butylphenol] results in increased expression of NANOG mRNA
CTD
PMID:36682590
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
G
Pax3
paired box 3
multiple interactions
ISO
[Chir 99021 co-treated with 2,4-di-tert-butylphenol] results in decreased expression of PAX3 mRNA
CTD
PMID:36682590
NCBI chr 9:79,567,455...79,664,042
Ensembl chr 9:79,568,634...79,664,042
G
Pax9
paired box 9
multiple interactions
ISO
[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with Fibroblast Growth Factor 2] results in decreased expression of PAX9 mRNA
CTD
PMID:36682590
NCBI chr 6:74,186,749...74,203,508
Ensembl chr 6:74,182,568...74,203,506
G
Pou5f1
POU class 5 homeobox 1
multiple interactions
ISO
[Chir 99021 co-treated with 2,4-di-tert-butylphenol] results in increased expression of POU5F1 mRNA
CTD
PMID:36682590
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
G
Runx2
RUNX family transcription factor 2
multiple interactions
ISO
[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with Fibroblast Growth Factor 2 co-treated with Ascorbic Acid co-treated with alpha-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of RUNX2 mRNA
CTD
PMID:36682590
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
Sp7
Sp7 transcription factor
multiple interactions
ISO
[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with Fibroblast Growth Factor 2 co-treated with Ascorbic Acid co-treated with alpha-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of SP7 mRNA
CTD
PMID:36682590
NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:133,484,609...133,494,847
G
Spp1
secreted phosphoprotein 1
multiple interactions
ISO
[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with Fibroblast Growth Factor 2 co-treated with Ascorbic Acid co-treated with alpha-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA
CTD
PMID:36682590
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Tbx6
T-box transcription factor 6
multiple interactions
ISO
[Chir 99021 co-treated with 2,4-di-tert-butylphenol] results in decreased expression of TBX6 mRNA
CTD
PMID:36682590
NCBI chr 1:181,387,851...181,392,762
Ensembl chr 1:181,388,684...181,392,593
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
increases activity
ISO
2,4-di-tert-butylphenol results in increased activity of TRPA1 protein
CTD
PMID:21591660 PMID:29658714
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
increases activity
ISO
2,4-di-tert-butylphenol results in increased activity of TRPV3 protein
CTD
PMID:29658714
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all